OpenVSafe by OpenVAERS
Search V-safe

4WZ-10730-26590

3 vaccinations 4 coded responses 13 check-ins 4 free-text entries 0 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
631 / MO
Registered
2021-03-28
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-25
    Dose 1 — Moderna
  2. 2021-03-28
    Registered in v-safe
  3. 2021-03-28
    Survey response — days 1–6 daily, dose 1
    MedDRA: Lymphadenopathy — Feeling: Fair · Headache, Nausea · Be unable to do your normal daily activities
    Free text: Very swollen lymph nodes in neck
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-03-29
    Survey response — days 1–6 daily, dose 1
    MedDRA: Lymphadenopathy — Feeling: Fair · Fatigue or tiredness
    Free text: Swollen lymph nodes in neck
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-03-30
    Survey response — days 1–6 daily, dose 1
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: Swollen lymph node in neck
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-04-03
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-04-23
    Dose 2 — Moderna
  8. 2021-04-24
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  9. 2021-04-26
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Headache
    Adult check-in
  10. 2021-04-27
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  11. 2021-04-29
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  12. 2021-05-02
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  13. 2021-10-24
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  14. 2022-01-15
    Dose 3 — Moderna
  15. 2022-01-16
    Health check-in — days 1–6 daily, dose 3
    Feeling: Poor · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  16. 2022-01-17
    Survey response — days 1–6 daily, dose 3
    MedDRA: Chest pain, Tachycardia — Feeling: Fair · Site: Pain · Headache
    Free text: Tachycardia, chest pain
    MedDRA releases: 2024-11 · check-in free text available
  17. 2022-01-18
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-03-25Moderna
22021-04-23Moderna
32022-01-15Moderna No

Free text

Release 6 — days 1–6 daily, dose 1

2021-03-28

Systemic reaction (other): Very swollen lymph nodes in neck

2021-03-29

Systemic reaction (other): Swollen lymph nodes in neck

2021-03-30

Systemic reaction (other): Swollen lymph node in neck

Release 10 — days 1–6 daily, dose 3

2022-01-17

Systemic reaction (other): Tachycardia, chest pain

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SROChest pain · · ✓
SROLymphadenopathy ✓ ✓ ✓
SROTachycardia · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…